Emrosi (minocycline hydrochloride extended-release capsules) is now available for the treatment of inflammatory lesions (papules and pustules) of rosacea in adults.

Patients with rosacea experienced improvement with Emrosi, an oral minocycline hydrochloride extended-release product, ...

FDA Approval of Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) for Rosacea Emrosi Initial Distribution Ongoing; First Prescriptions Filled Total Revenues for the Full Year ...

FDA Approval of Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules) for RosaceaEmrosi Initial Distribution Ongoing; First ...

The medication can be taken with or without food, though ingestion of food along with Emrosi may help reduce the risk of esophageal irritation and ulceration. Emrosi ™ (minocycline hydrochloride ...

A new study published in the Journal of American Medical Association showed that patients with moderate to severe papulopustular rosacea responded better to a low-dose (40 mg) modified formulation of ...

Roshni Nadar Malhotra, daughter of HCL founder Shiv Nadar, became India's richest woman and the third-richest person overall after acquiring 47% of her father's stake in HCL Corporation and Vama ...